Study on feasibility of changing to cyclosporine from tacrolimus for better glycemic control in liver transplant recepients

被引：0
|
作者：
Raghuram, C. [1 ]
Aggarwal, S. [2 ]
Naganathan, S. K. [2 ]
Kandagaddala, R. [2 ]
Gupta, S. [2 ]
机构：
[1] Max Super Special Hosp, New Delhi, India
[2] Max Super Special Hosp, Ctr Liver & Biliary Sci, New Delhi, India
来源：
TRANSPLANTATION | 2019年 / 103卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-423
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [41] Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight
    Neal, DAJ
    Gimson, AES
    Gibbs, P
    Alexander, GJM
    LIVER TRANSPLANTATION, 2001, 7 (06) : 533 - 539
  • [42] Tacrolimus pharmacokinetic study in Asian liver transplant patients
    Yee, M-L
    Tan, H-H
    Sia, W. J.
    Kwa, A.
    Yau, W. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 163 - 163
  • [43] Tacrolimus/cerivastatin interaction study in liver transplant recipients
    Mück, W
    Neal, DAJ
    Boix, O
    Voith, B
    Hasan, R
    Alexander, GJM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (02) : 213 - 215
  • [44] Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: Randomized, prospective, multicenter pilot study results
    Reich, DJ
    Clavien, PA
    Hodge, EE
    TRANSPLANTATION, 2005, 80 (01) : 18 - 25
  • [45] Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.
    Canzanello, VJ
    Schwartz, LL
    Taler, SJ
    Textor, SC
    Atwood, G
    Porayko, MK
    Wiesner, RH
    Krom, RAF
    HEPATOLOGY, 1997, 26 (04) : 1443 - 1443
  • [46] Case study: Conversion of a liver transplant patient from cyclosporine sandimmune to neoral
    Levy, GA
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2252 - 2253
  • [47] Intraoperative and postoperative glycemic control & AKI in liver transplant recipients
    Ryu, Ho Geol
    Jang, Hye-Ryoun
    Lee, Hannah
    Yoo, Seokha
    Kwon, Wooil
    Jeon, Yoon-suk
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [48] Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus)
    Van Buren, D
    Payne, J
    Geevarghese, S
    MacDonell, R
    Chapman, W
    Wright, JK
    Helderman, JH
    Richie, R
    Pinson, CW
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1401 - 1402
  • [49] Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients
    Colak, T
    Karakayali, H
    Yagmurdur, MC
    Moray, G
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2081 - 2082
  • [50] Conversion from cyclosporine to tacrolimus based immunosuppression therapy in renal transplant recipients
    Backman, Lars
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A33 - A33
12345